275 related articles for article (PubMed ID: 10773012)
1. Altered regulation of the D(1) dopamine receptor in mutant Chinese hamster ovary cells deficient in cyclic AMP-dependent protein kinase activity.
Ventura AL; Sibley DR
J Pharmacol Exp Ther; 2000 May; 293(2):426-34. PubMed ID: 10773012
[TBL] [Abstract][Full Text] [Related]
2. Regulation of D(1) dopamine receptors with mutations of protein kinase phosphorylation sites: attenuation of the rate of agonist-induced desensitization.
Jiang D; Sibley DR
Mol Pharmacol; 1999 Oct; 56(4):675-83. PubMed ID: 10496949
[TBL] [Abstract][Full Text] [Related]
3. The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells.
Zhang LJ; Lachowicz JE; Sibley DR
Mol Pharmacol; 1994 May; 45(5):878-89. PubMed ID: 7910658
[TBL] [Abstract][Full Text] [Related]
4. Cyclic AMP-mediated desensitization of D1 dopamine receptor-coupled adenylyl cyclase in NS20Y neuroblastoma cells.
Black LE; Smyk-Randall EM; Sibley DR
Mol Cell Neurosci; 1994 Dec; 5(6):567-75. PubMed ID: 7704430
[TBL] [Abstract][Full Text] [Related]
5. Agonist-induced desensitization of D1-dopamine receptors linked to adenylyl cyclase activity in cultured NS20Y neuroblastoma cells.
Barton AC; Sibley DR
Mol Pharmacol; 1990 Oct; 38(4):531-41. PubMed ID: 1978240
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the laminin beta 1 (LAMB1), retinoic acid receptor beta, and bone morphogenetic protein 2 genes in mutant F9 teratocarcinoma cell lines partially deficient in cyclic AMP-dependent protein kinase activity.
Shen J; Li C; Gudas LJ
Cell Growth Differ; 1997 Dec; 8(12):1297-304. PubMed ID: 9419418
[TBL] [Abstract][Full Text] [Related]
7. Low expression of lipid-linked oligosaccharide due to a functionally altered Dol-P-Man synthase reduces protein glycosylation in cAMP-dependent protein kinase deficient Chinese hamster ovary cells.
Banerjee DK; Aponte E; Dasilva JJ
Glycoconj J; 2004; 21(8-9):479-86. PubMed ID: 15750789
[TBL] [Abstract][Full Text] [Related]
8. Homologous desensitization of the D1A dopamine receptor: efficacy in causing desensitization dissociates from both receptor occupancy and functional potency.
Lewis MM; Watts VJ; Lawler CP; Nichols DE; Mailman RB
J Pharmacol Exp Ther; 1998 Jul; 286(1):345-53. PubMed ID: 9655879
[TBL] [Abstract][Full Text] [Related]
9. Altered patterns of agonist-stimulated cAMP accumulation in cells expressing mutant beta 2-adrenergic receptors lacking phosphorylation sites.
Liggett SB; Bouvier M; Hausdorff WP; O'Dowd B; Caron MG; Lefkowitz RJ
Mol Pharmacol; 1989 Oct; 36(4):641-6. PubMed ID: 2554115
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D2 receptor signaling via the arachidonic acid cascade: modulation by cAMP-dependent protein kinase A and prostaglandin E2.
Piomelli D; Di Marzo V
J Lipid Mediat; 1993; 6(1-3):433-43. PubMed ID: 8395253
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons.
Sasaki T; Kotera J; Omori K
J Neurochem; 2004 Apr; 89(2):474-83. PubMed ID: 15056290
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the potential phosphorylation sites for protein kinase C on the CCK(A) receptor.
Smeets RL; Fouraux MA; Pouwels W; van Emst-de Vries SE; Ronken E; De Pont JJ; Willems PH
Br J Pharmacol; 1998 Jul; 124(5):935-45. PubMed ID: 9692779
[TBL] [Abstract][Full Text] [Related]
13. Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636.
Lin CW; Bianchi BR; Miller TR; Stashko MA; Wang SS; Curzon P; Bednarz L; Asin KE; Britton DR
J Pharmacol Exp Ther; 1996 Mar; 276(3):1022-9. PubMed ID: 8786531
[TBL] [Abstract][Full Text] [Related]
14. Regulation of dopamine D-receptor activation in vivo by protein phosphatase 2B (calcineurin).
Adlersberg M; Hsiung SC; Glickstein SB; Liu KP; Tamir H; Schmauss C
J Neurochem; 2004 Aug; 90(4):865-73. PubMed ID: 15287892
[TBL] [Abstract][Full Text] [Related]
15. Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies.
Tran TM; Friedman J; Qunaibi E; Baameur F; Moore RH; Clark RB
Mol Pharmacol; 2004 Jan; 65(1):196-206. PubMed ID: 14722251
[TBL] [Abstract][Full Text] [Related]
16. D2 dopamine receptor stimulation of mitogenesis in transfected Chinese hamster ovary cells: relationship to dopamine stimulation of tyrosine phosphorylations.
Lajiness ME; Chio CL; Huff RM
J Pharmacol Exp Ther; 1993 Dec; 267(3):1573-81. PubMed ID: 7903393
[TBL] [Abstract][Full Text] [Related]
17. [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor.
Moreland RB; Terranova MA; Chang R; Uchic ME; Matulenko MA; Surber BW; Stewart AO; Brioni JD
Eur J Pharmacol; 2004 Aug; 497(2):147-54. PubMed ID: 15306199
[TBL] [Abstract][Full Text] [Related]
18. Intracellular localization of the catalytic subunit from cyclic AMP-dependent protein kinase in mutant Chinese hamster ovary cells deficient in this enzyme.
Byus CV; Fletcher WH
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(1):9-22. PubMed ID: 4038984
[TBL] [Abstract][Full Text] [Related]
19. Cloning, expression, and functional analysis of human dopamine D1 receptors.
Sun WC; Jin L; Cao Y; Wang LZ; Meng F; Zhu XZ
Acta Pharmacol Sin; 2005 Jan; 26(1):27-32. PubMed ID: 15659110
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.
Jordan S; Johnson JL; Regardie K; Chen R; Koprivica V; Tadori Y; Kambayashi J; Kitagawa H; Kikuchi T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):348-56. PubMed ID: 17070976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
